While mammalian adult neurogenesis is limited, zebrafish are able to generate new neurons and repair brain damage lifelong. The in vivo mechanisms underlying neural stem cell proliferation and precursor pool expansion as well as the specific differentiation of stem cell-derived precursors are poorly understood. Hairy and enhancer of split (Hes) family genes inhibit neurogenesis to allow stem cell pool expansion and maintenance, and thus differentiation of neurons also at later stages. Most Hes genes are still expressed in stem cell zones of adult zebrafish, but it is unknown how these niches form. Therefore, zebrafish Hes gene knockout models may provide additional information on the function of these genes and their roles during the establishment of stem cell niches.
While mammalian adult neurogenesis is limited, zebrafish are able to generate new neurons and repair brain damage lifelong. The in vivo mechanisms underlying neural stem cell proliferation and precursor pool expansion as well as the specific differentiation of stem cell-derived precursors are poorly understood. Hairy and enhancer of split (Hes) family genes inhibit neurogenesis to allow stem cell pool expansion and maintenance, and thus differentiation of neurons also at later stages. Most Hes genes are still expressed in stem cell zones of adult zebrafish, but it is unknown how these niches form. Therefore, zebrafish Hes gene knockout models may provide additional information on the function of these genes and their roles during the establishment of stem cell niches.
Since loss of Hes1 and Hes5 in mice causes premature differentiation followed by loss of radial glia, we focus on the zebrafish Hes1 homologs her6 and her9 as well as on the Hes5 homologs. There are nine zebrafish Hes5 homologs located in only two gene clusters, which enabled us to create deletions of all Hes5 type genes using the CRISPR/Cas9 system. We analyze phenotypes of the deletion alleles for changes in expression of her genes, proneural genes and stem cell markers. To better understand her gene functions during neural stem cell niche formation, we characterize and compare the expression of her and proneural genes using double-fluorescent in-situ hybridizations at larval stages (3-5 days old). We also correlate her gene expression with stem cell and progenitor properties by staining for stem cell markers in wild-type and her gene mutant fish. Together this will help to elucidate with high spatio-temporal resolution the function of her genes during the establishment of stem cell zones. Asrij/OCIAD1 is a critical factor required for generation and maintenance of Drosophila blood stem cells. However, its involvement in mouse and human hematopoiesis remains unclear. To elucidate the role of mammalian Asrij, we generated and analyzed knockout mice by global deletion of asrij. We find that asrij knockout mice progress into a myeloproliferative disorder and have increased peripheral blood and bone marrow (BM) stem cell counts by six months of age. Mice deficient for Asrij develop enlarged spleens enriched for myeloid progenitors and granulocytes. Long termhematopoietic stem cells (LT-HSCs) from Asrij knockout mice show significantly increased proliferative capacity with an accelerated differentiation of BM cells towards the myeloid lineage in vitro. In non-competitive repopulation assays, knockout BM cells show increased repopulation ability in primary and secondary transplants. Moreover, mutants are more susceptible to stress with chemotherapeutic agent 5-fluorouracil (5-FU). Drosophila Asrij is known to affect cellular trafficking and degradation pathways. Biochemical analysis showed that knockout bone marrow has increased levels of COP9 signalosome subunit 5 (CSN5) and ubiquitin. CSN5 is a negative regulator of p53. In asrij mutants, p53 levels are reduced though p53 transcript levels remain unaltered. Further, we show that Asrij binds CSN5 through its OCIA domain but does not interact with p53. Thus, Asrij is a critical positive regulator of p53 in bone marrow hematopoiesis. This is the first insight into the normal role of mammalian Asrij providing a novel post-transcriptional modulator of p53 that may shed light on protective mechanisms against cancer. Asrij knockout mice provide a valuable model to study human myeloproliferative disorders. Mesenchymal stem cells (MSC) comprise a promising tool for cellular therapy. These cells are usually culture expanded prior to their application. However, a precise molecular definition of MSC and the sequel of long-term in vitro culture are yet unknown. The purpose of this study was to compare the accelerated senescence/ replicative senescence in MSCs isolated from human bone marrow (BMMSC), adipose tissue (ATMSC), and umbilical cord blood (UCBMSC) and wharton's jelly (WJMSC). MSC proliferation (BrdU or cell doubling), senescence-associated β-galactosidase staining, telomere length (TERT), Sox-2, Oct-4, Nonog and lineagespecific marker (SMA, Vimentin, Osteonectin) expression were assessed for MSCs harvested from tissues of 3 different donors. The results show that before senescence ensued, all cell types proliferated at 2±1 day/ cell doubling. ATMSCs significantly increased population doubling rate by passage 3 and ceased proliferation after a little N 11 total population doublings, whereas UCBMSCs, WJMSCS and BMMSCS achieved about 50-60 total population doublings. The onset of senescence was associated TERT gene expression in senescent cultures. Sox-2, Oct-4 and Nonog gene expression was consistently noted in all 4 MSC types. In conclusion, Human UCBMSCs appear to senesce much earlier than BMMSCs, ATMSCs and WJMSCs. These results demonstrate the limited passage numbers of subcultured UCBMSCs available for use in research and tissue engineering and suggest that bone marrow, adipose tissue and wharton's jelly tissue may be preferable for tissue banking purposes. Our studies indicate that replicative senescence of MSC preparations is a continuous process starting from the first passage onwards. This process includes far reaching alterations in phenotype, differentiation potential, global gene expression patterns, and senescence-associated β-galactosidase staining that need to be considered for therapeutic application of MSC preparations. doi:10.1016/j.mod.2017.04.499 Abstracts S172
